Cambridge Investment Research Advisors, Inc. AOCT INNOVATOR ETFS TRUST EQUITY DEF PRO

Ownership history in Cambridge Investment Research Advisors, Inc.  ·  7 quarters on record

AI Ownership Summary

Cambridge Investment Research Advisors, Inc. reported INNOVATOR ETFS TRUST EQUITY DEF PRO (AOCT) in 7 quarterly 13F filings from 2024 Q4 through 2026 Q2. The latest visible filing shows AOCT at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this AOCT ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Cambridge Investment Research Advisors, Inc.'s position in INNOVATOR ETFS TRUST EQUITY DEF PRO, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

AOCT was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Cambridge Investment Research Advisors, Inc. held AOCT — position size vs. price
% of Fund (quarterly)    AOCT price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 19,952 -500 -2.4% 0.00% $546 2026-07-30 $27.44
2026 Q1 REDUCED 19.7% +3.1% 20,452 -5,022 -19.7% 0.00% $541 2026-04-30 $27.02
2025 Q4 REDUCED 13.3% -0.4% 25,474 -3,898 -13.3% 0.00% $677K 2026-02-05 $26.60
2025 Q3 ADDED 29,372 +1,377 +4.9% 0.00% $771K 2025-11-12 $26.33
2025 Q2 ADDED 27,995 +205 +0.7% 0.00% $720K 2025-07-31 $25.82
2025 Q1 REDUCED 5.3% +3.5% 27,790 -1,563 -5.3% 0.00% $690K 2025-04-22 $24.58
2024 Q4 INITIATED 29,353 0.00% $730K 2025-02-14 $25.19

FAQ About Cambridge Investment Research Advisors, Inc. and AOCT

These are the practical questions this page is built to answer before you even open the full history table.

How long has Cambridge Investment Research Advisors, Inc. reported owning AOCT?

Cambridge Investment Research Advisors, Inc. reported AOCT across 7 quarterly 13F filings, from 2024 Q4 through 2026 Q2.

What was the largest reported AOCT position in Cambridge Investment Research Advisors, Inc.'s portfolio?

The largest reported portfolio weight for AOCT was 0.00% in 2024 Q4.

What is the latest reported AOCT position on this page?

The most recent filing on this page is 2026 Q2, when Cambridge Investment Research Advisors, Inc. reported 19,952 shares, equal to 0.00% of portfolio, with an estimated market value of $546.

What does the chart on this AOCT ownership page compare?

The chart compares Cambridge Investment Research Advisors, Inc.'s quarterly AOCT portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Cambridge Investment Research Advisors, Inc. time their AOCT position?

Based on 13F filing dates vs. subsequent AOCT price moves, Cambridge Investment Research Advisors, Inc. correctly timed 2 out of 6 reported position changes (33%). The annualised alpha on AOCT relative to SPY over the holding period was +101.7%.

← Back to Cambridge Investment Research Advisors, Inc. Holdings